Wells Fargo Remains a Hold on National Health Investors (NHI)
Wells Fargo analyst John Kilichowski maintained a Hold rating on National Health Investors (NHI) with a price target of $89.00. The company reported strong quarterly revenues and net profits, and corporate insider sentiment is positive with recent insider share purchases. The analyst consensus on …